価格表

在庫・価格 : 2026年04月06日 21時32分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TRAIL R1/TNFRSF10A, Mouse-Mono(32A242)
データシート※最新のデータシートでない場合があります
NB100-56528SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 mg ¥41,000
(未発注)
追加

在庫・価格 : 2026年04月06日 21時32分 現在

Anti-TRAIL R1/TNFRSF10A, Mouse-Mono(32A242)

  • 商品コード:NB100-56528SS
  • メーカー:NOV
  • 包装:0.025mg
  • 価格: ¥41,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Cisternas P et al. Comparative analysis of apoptotic pathways in rat, mouse, and hamster spermatozoa. Mol. Reprod. Dev. 2006 Oct;73(10):1318-25
Cisternas P et al
2006/01/01
Applications: WB PubMed
2 Jin F et al. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells. Cancer Res. 2005 Jul;65(14):6354-63
Jin F et al
2005/01/01
Applications: WB PubMed
3 Xu J et al. Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. Cancer Res. 2006 Oct;66(20):10092-9
Xu J et al
2006/01/01
Applications: PubMed
4 Brooks AD et al. Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex. Mol. Cancer Res. 2010 May;8(5):729-38
Brooks AD et al
2010/01/01
Applications: PubMed
5 Laguinge LM et al. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Cancer Res. 2008 Feb;68(3):909-17
Laguinge LM et al
2008/01/01
PubMed
  • No.: 1
  • 文献情報:
    Cisternas P et al. Comparative analysis of apoptotic pathways in rat, mouse, and hamster spermatozoa. Mol. Reprod. Dev. 2006 Oct;73(10):1318-25
    Cisternas P et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Jin F et al. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells. Cancer Res. 2005 Jul;65(14):6354-63
    Jin F et al
    2005/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Xu J et al. Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. Cancer Res. 2006 Oct;66(20):10092-9
    Xu J et al
    2006/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Brooks AD et al. Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex. Mol. Cancer Res. 2010 May;8(5):729-38
    Brooks AD et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Laguinge LM et al. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Cancer Res. 2008 Feb;68(3):909-17
    Laguinge LM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed